跳至主要内容
临床试验/JPRN-UMIN000040727
JPRN-UMIN000040727尚未招募4 期

The crossover randomized controlled clinical trial with Alirocumab and Evolocumab:CROSS ALIVE Study - The crossover randomized controlled clinical trial with Alirocumab and Evolocumab:CROSS ALIVE Study

Saitama Medical University Dept. of Endocrinology and Diabetology0 个研究点目标入组 20 人开始时间: 2020年6月12日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
20